Cambridge Investment Research Advisors’s NUVEEN PREMIUN INC MUN FUND NPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-27,899
Closed -$430K 1815
2016
Q2
$430K Buy
27,899
+4,551
+19% +$68.1K 0.01% 1003
2016
Q1
$340K Buy
23,348
+2,712
+13% +$38.7K 0.01% 1106
2015
Q4
$291K Buy
20,636
+3,875
+23% +$52.9K 0.01% 1140
2015
Q3
$225K Sell
16,761
-8,102
-33% -$107K 0.01% 1193
2015
Q2
$327K Buy
24,863
+10,633
+75% +$144K 0.01% 1020
2015
Q1
$200K Sell
14,230
-5,197
-27% -$72.8K 0.01% 1256
2014
Q4
$269K Buy
19,427
+6
+0% +$82 0.01% 1062
2014
Q3
$260K Buy
19,421
+6,218
+47% +$83.7K 0.01% 1172
2014
Q2
$179K Buy
13,203
+405
+3% +$5.45K 0.01% 1225
2014
Q1
$168K Buy
+12,798
New +$167K 0.01% 1179
2013
Q4
Sell
-14,519
Closed -$186K 1302
2013
Q3
$186K Sell
14,519
-5,400
-27% -$67.3K 0.01% 1062
2013
Q2
$265K Buy
+19,919
New +$281K 0.01% 808

Other funds holding NPI

Cambridge Investment Research Advisors's NPI Position: Q3 2016 in Review

Cambridge Investment Research Advisors sold out of NUVEEN PREMIUN INC MUN FUND (NPI) in Q3 2016, closing a stake of 27,899 shares — an estimated $430K sold.

Cambridge Investment Research Advisors first reported a position in NPI in Q2 2013 and held it in 12 quarters. The position peaked at $430K in Q2 2016. 1 fund tracked by Wall St. Rank holds NPI as of Q3 2016.

  • Cambridge Investment Research Advisors reported no remaining NUVEEN PREMIUN INC MUN FUND position as of Q3 2016 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 27,899 NUVEEN PREMIUN INC MUN FUND shares in Q3 2016, an estimated $430K.
  • Cambridge Investment Research Advisors first reported a position in NUVEEN PREMIUN INC MUN FUND in Q2 2013 and held it in 12 quarters.
  • Cambridge Investment Research Advisors's NUVEEN PREMIUN INC MUN FUND position peaked at $430K in Q2 2016.
  • 1 fund tracked by Wall St. Rank held NUVEEN PREMIUN INC MUN FUND as of Q3 2016.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.